Hyperinsulinism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-06-13
Clinical Trial Update: Sirolimus for the Treatment of Hyperinsulinism [Phase 1, Phase 2]
The clinical trial evaluating sirolimus for hyperinsulinism (Phase 1/2) has been withdrawn.